Editorial
doi: 10.1002/ejhf.404.
Epub 2015 Oct 7.
Hyperkalaemia in heart failure: binding the patient to improved treatment?
Affiliations
- PMID: 26443125
- DOI: 10.1002/ejhf.404
Item in Clipboard
Editorial
Hyperkalaemia in heart failure: binding the patient to improved treatment?
Eur J Heart Fail.
2015 Oct.
Free article
No abstract available
Comment in
-
Response to: Hyperkalaemia in heart failure: binding the patient to improved treatment?Eur J Heart Fail. 2016 Feb;18(2):216. doi: 10.1002/ejhf.452. Epub 2015 Dec 3. Eur J Heart Fail. 2016. PMID: 26634417 Free PMC article. No abstract available.
Comment on
-
Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.Eur J Heart Fail. 2015 Oct;17(10):1050-6. doi: 10.1002/ejhf.300. Epub 2015 Jun 16. Eur J Heart Fail. 2015. PMID: 26011677 Free PMC article. Clinical Trial.
-
Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors.Eur J Heart Fail. 2015 Oct;17(10):1057-65. doi: 10.1002/ejhf.402. Epub 2015 Oct 12. Eur J Heart Fail. 2015. PMID: 26459796 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
